Ziprasidon (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ziprasidon" in Serbian language version.

refsWebsite

Global rank Serbian rank

4^th place

8^th place

2^nd place

4^th place

1mcgraw-hill.com

low place

288^th place

low place

984^th place

1web.archive.org

1^st place

1^st place

1healthyplace.com

low place

low place

234^th place

287^th place

doi.org

Tatsumi M, Jansen K, Blakely RD, Richelson E (1999). „Pharmacological profile of neuroleptics at human monoamine transporters”. Eur J Pharmacol. 368 (2–3): 277—283. PMID 10193665. doi:10.1016/S0014-2999(99)00005-9.
Marek GJ, Carpenter LL, McDougle CJ, Price LH (2003). „Synergistic action of 5-HT_2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders”. Neuropsychopharmacology. 28 (2): 402—12. PMID 12589395. doi:10.1038/sj.npp.1300057.

healthyplace.com

„Ziprasidone full prescribing information”. Архивирано из оригинала 24. 12. 2011. г. Приступљено 22. 03. 2012.

mcgraw-hill.com

books.mcgraw-hill.com

Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). Goodman & Gilman's The Pharmacological Basis of Therapeutics (11. изд.). New York: McGraw-Hill. ISBN 0071422803.

nature.com

Marek GJ, Carpenter LL, McDougle CJ, Price LH (2003). „Synergistic action of 5-HT_2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders”. Neuropsychopharmacology. 28 (2): 402—12. PMID 12589395. doi:10.1038/sj.npp.1300057.

nih.gov

ncbi.nlm.nih.gov

Nemeroff, CB; JA, Lieberman; Weiden, PJ; PD, Harvey; Newcomer, JW; AF, Schatzberg; Kilts, CD; Daniel DG. (2005). „From clinical research to clinical practice: a 4-year review of ziprasidone”. CNS Spectr. 10 (11 Suppl 17): 1—20. PMID 16381088.
Tatsumi M, Jansen K, Blakely RD, Richelson E (1999). „Pharmacological profile of neuroleptics at human monoamine transporters”. Eur J Pharmacol. 368 (2–3): 277—283. PMID 10193665. doi:10.1016/S0014-2999(99)00005-9.
Marek GJ, Carpenter LL, McDougle CJ, Price LH (2003). „Synergistic action of 5-HT_2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders”. Neuropsychopharmacology. 28 (2): 402—12. PMID 12589395. doi:10.1038/sj.npp.1300057.
Seeger TF, Seymour PA, Schmidt AW, Zorn SH, Schulz DW, Lebel LA, McLean S, Guanowsky V, Howard HR, Lowe JA (1995). „Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity”. J Pharmacol Exp Ther. 275 (1): 101—13. PMID 7562537.

pdr.net

Pdr Staff (2009). PDR: Physicians Desk Reference 2010 (Physicians' Desk Reference (Pdr)). Rozelle, N.S.W: Thomson Reuters. ISBN 1-56363-748-0.

web.archive.org

„Ziprasidone full prescribing information”. Архивирано из оригинала 24. 12. 2011. г. Приступљено 22. 03. 2012.